Surg Today (2018) 48:119–126 https://doi.org/10.1007/s00595-017-1546-2 ORIGINAL ARTICLE Human CD200 suppresses macrophage‑mediated xenogeneic cytotoxicity and phagocytosis 1 1 1 1 1 Rieko Sakai · Akira Maeda · Thuy‑Vy Choi · Pei‑Chi Lo · Patmika Jiaravuthisan · 1 1 1 1 Afifah Mod Shabri · Han‑Tang Wang · Rei Matsuura · Tasuku Kodama · 1 1 1 Hiroshi Eguchi · Hiroomi Okuyama · Shuji Miyagawa Received: 14 February 2017 / Accepted: 22 May 2017 / Published online: 1 June 2017 © Springer Japan 2017 Abstract Conclusions Our findings indicate that human CD200 Purpose Various strategies, such as the generation of suppresses the xenogeneic rejection by CD200R mac- alpha-1,3-galactosyltransferase knocked-out pigs and rophages and that the generation of hCD200 transgenic CD55 transgenic pigs, have been investigated to inhibit pig pigs for use in xenografts is very attractive for preventing to human xenogeneic rejection. Our aim is to develop strat- the macrophage-mediated rejection. egies to overcome the hurdle of not only hyper acute rejec- tion, but also that of cellular xenogeneic rejection (CXR). Keywords CD200 · CD200R · Macrophage · Although macrophages have been well known to play a Xenotransplantation critical role in CXR, monocyte/macrophage-mediated xen- ogeneic rejection has not been well studied.
Surgery Today – Springer Journals
Published: Jun 1, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera